Author:
Mane Mayuresh M.,Cohen Ivan J.,Ackerstaff Ellen,Shalaby Khalid,Ijoma Jenny N.,Ko Myat,Maeda Masatomo,Albeg Avi S.,Vemuri Kiranmayi,Satagopan Jaya,Moroz Anna,Zurita Juan,Shenker Larissa,Shindo Masahiro,Nickles Tanner,Nikolov Ekaterina,Moroz Maxim A.,Koutcher Jason A.,Serganova Inna,Ponomarev Vladimir,Blasberg Ronald G.
Funder
U.S. Department of Defense
Foundation for the National Institutes of Health
Subject
Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine
Reference60 articles.
1. The market for chimeric antigen receptor T cell therapies;Yip;Nat. Rev. Drug Discov.,2018
2. Target selection of CAR T cell therapy in accordance with the TME for solid tumors;Liu;Am. J. Cancer Res.,2019
3. Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate;Bunse;Nat. Med.,2018
4. The tricarboxylic acid cycle at the crossroad between cancer and immunity;Scagliola;Antioxid. Redox Signal.,2020
5. On respiratory impairment in cancer cells;Warburg;Science,1956
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献